Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

The Society for Translational Oncology

Assessing and Improving Value in Cancer Care -Potential Actions for Improvement of Existing Systems

Access Activity

Overview / Abstract:

1. Describe the factors that can change the clinical value of a drug after the cost-effectiveness studies performed at its initial introduction into the market.
2. Describe coverage with evidence development (CED) and explain how CED may promote greater certainty regarding research conclusions regarding the value of cancer treatments and better inform post-regulatory decision makers.
3. Discuss the limitations of randomized controlled trials to inform clinicians regarding the effectiveness of cancer treatments in the real world and promote the use of large, simple clinical trials, cluster randomized trial design, and registry data to more directly assess treatment effectiveness.
4. Identify unique aspects of oncology that compound clinical uncertainty regarding treatment effectiveness.


Mar 17, 2012


Physician CME



Credits / Hours

1 AMA PRA Category 1 Credit

Activity Specialities / Related Topics

Oncology / Cancer / Radiation Therapy, Oncology / Cancer / Radiation Therapy

Keywords / Search Terms

The Society for Translational Oncology cancer biology, breast cancer, dialogues in oncology, GI cancer, lung cancer, leukemias, lymphoma, cancer medicine, melanoma

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.